Profil
Dr. Robert H.
Pierce, MD, is a Chief Scientific Officer at Ernexa Therapeutics, Inc. Dr. Pierce was previously employed as a Chief Scientific Officer by Sensei Biotherapeutics, Inc., a Chief Research & Development Officer by Sensei Biotherapeutics, Inc., a Scientific Director by Fred Hutchinson Cancer Research Center, a Chief Scientific Strategist by OncoSec Medical, Inc., a Co-Founder by Alvaxa Biosciences, Inc., and an Executive Director by Merck Research Laboratories Massachusetts LLC.
He received his undergraduate degree from Yale College and a doctorate degree from Brown University.
Aktive Positionen von Robert Pierce
| Unternehmen | Position | Beginn |
|---|---|---|
| ERNEXA THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Robert Pierce
| Unternehmen | Position | Ende |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 07.12.2022 |
| FAETH THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2022 |
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Provides research and testing services | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2020 |
Alvaxa Biosciences, Inc.
Alvaxa Biosciences, Inc. BiotechnologyHealth Technology Develops camelid antibodies, or nanobodies | Gründer | - |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Direktor/Vorstandsmitglied | - |
Ausbildung von Robert Pierce
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
OncoSec Medical, Inc.
OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Provides research and testing services | Commercial Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Yale College
Yale College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alvaxa Biosciences, Inc.
Alvaxa Biosciences, Inc. BiotechnologyHealth Technology Develops camelid antibodies, or nanobodies | Health Technology |
Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Eterna Therapeutics, Inc.
Eterna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer | Health Technology |
















